首页|初治涂阳肺结核患者预后不良的影响因素

初治涂阳肺结核患者预后不良的影响因素

扫码查看
目的:分析初治涂阳肺结核患者预后不良的影响因素.方法:选取2018年1月至2022年12月通许县疾病预防控制中心收治的203 例初治涂阳肺结核患者进行横断面研究,所有患者均予以 2HRZE/4HR抗结核方案治疗,治疗后 3 个月评估预后情况,采用Logistic回归分析初治涂阳肺结核患者预后不良的影响因素.结果:203 例初治涂阳肺结核患者中,预后不良 55 例,占 27.09%(55/203),设为预后不良组,预后良好 148 例,设为预后良好组.预后不良组年龄≥40 岁、体质量指数<18.5 kg/m2、文化程度高中及以下、合并肺部感染、病情程度中重度、血清γ干扰素(IFN-γ)<10.73 pg/mL、CD3+<53.86%、CD4+<32.71%、CD4+/CD8+<0.93、白细胞介素(IL)-15≥42.85 ng/mL、序贯器官衰竭(SOFA)评分≥2.46 分、急性生理与慢性健康Ⅱ(APACHEⅡ)评分≥7.82 分、高分辨率CT(HRCT)评分≥42.26 分等占比均高于预后良好组,差异有统计学意义(P<0.05);经Logistic回归分析结果显示,体质量指数<18.5 kg/m2、血清IFN-γ<10.73 pg/mL、CD3+<53.86%、CD4+<32.71%、CD4+/CD8+<0.93、IL-15≥42.85 ng/mL、SOFA评分≥2.46 分、APACHEⅡ评分≥7.82 分、HRCT评分≥42.26 分等均为影响初治涂阳肺结核患者预后不良的危险因素(OR>1,P<0.05).结论:体质量指数<18.5 kg/m2、血清IFN-γ<10.73 pg/mL、CD3+<53.86%、CD4+<32.71%、CD4+/CD8+<0.93、IL-15≥42.85 ng/mL、SOFA评分≥2.46 分、APACHEⅡ评分≥7.82 分、HRCT评分≥42.26 分等均为影响初治涂阳肺结核患者预后不良的危险因素.
Influencing factors of poor prognosis in patients with initial smear-positive pulmonary tuberculosis
Objective:To analyze influencing factors of poor prognosis in patients with initial smear-positive pulmonary tuberculosis.Methods:A cross-sectional study was conducted on 203 patients with initial smear-positive pulmonary tuberculosis admitted to Tongxu county center for disease control and prevention from January 2018 to December 2022.All patients were treated with 2HRZE/4HR anti-tuberculosis treatment.The prognosis was evaluated 3 months after treatment.According to the occurrence of poor prognosis,Logistic regression analysis was used to analyze the influencing factors of poor prognosis in the patients with initial smear-positive pulmonary tuberculosis.Results:Among the 203 initial smear-positive pulmonary tuberculosis patients,55 had a poor prognosis,accounting for 27.09%(55/203).They were assigned to the poor prognosis group.148 cases had good prognosis and they were assigned to the good prognosis group.The proportions of the patients with age≥40 years old,body mass index<18.5 kg/m2,educational level of high school or below,combined pulmonary infection,moderate to severe severity of the condition,serum IFN-γ level<10.73 pg/mL,CD3+<53.86%,CD4+<32.71%,CD4+/CD8+<0.93,Interleukin(IL)-15≥42.85 ng/mL,Sequential organ failure assessment(SOFA)score≥2.46 points,Acute Physiology and chronic health Ⅱ(APACHE Ⅱ)score≥7.82 points,High resolution CT(HRCT)score≥42.26 points in the poor prognosis group was higher than those in the good prognosis group,and the differences were statistically significant(P<0.05).Logistic regression analysis showed that body mass index<18.5 kg/m2,serum IFN-γ level<10.73 pg/mL,CD3+<53.86%,CD4+<32.71%,CD4+/CD8+<0.93,IL-15≥42.85 ng/mL,SOFA score≥2.46 points,APACHE Ⅱ score≥7.82 points and HRCT score≥42.26 points were all risk factors for poor prognosis in the patients with initial smear-positive pulmonary tuberculosis(OR>1,P<0.05).Conclusions:Body mass index<18.5 kg/m2,serum IFN-γ level<10.73 pg/mL,CD3+<53.86%,CD4+<32.71%,CD4+/CD8+<0.93,IL-15≥42.85 ng/mL,SOFA score≥2.46 points,APACHE Ⅱ score≥7.82 points and HRCT score≥42.26 points are the risk factors for poor prognosis in the patients with initial smear-positive pulmonary tuberculosis.

Pulmonary tuberculosisInitial treatmentPoor prognosisInfluencing factor

王治国、李建军、焦亚洲

展开 >

通许县疾病预防控制中心结核病防治科,河南 开封 475400

河南省胸科医院结核科,河南 郑州 450008

肺结核 初治 预后不良 影响因素

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(15)
  • 14